# lisdexamfetamine dimesylate

NDC: 0480-9744
Generic name: lisdexamfetamine dimesylate
Labeler / Manufacturer: Teva Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, CHEWABLE
Routes: ORAL
Marketing started: 20240916

FDA application: ANDA215415

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 60 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0480-9744"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0480-9744
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bdb03bfa-0398-41e5-8e73-ded696cbca32